Evidence map›Paper›PMID 31351498›Full record

ArticleLipids in health and disease2019

Effect of β-sitosterol self-microemulsion and β-sitosterol ester with linoleic acid on lipid-lowering in hyperlipidemic mice.

Chuanxun Yuan, Xueru Zhang, Xue Long, Jing Jin, Risheng Jin

Abstract read
In one paragraph

Article in Lipids in health and disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Aspects of β-sitosterol's Pharmacology, Nutrition and Analysis.Current pharmaceutical biotechnology · 2025
    Review
  3. Carob (Foods (Basel, Switzerland) · 2024
    Article
  4. Article
  5. Article
  6. Evidence-based complementary and alternative medicine : eCAM · 2023
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Oxidative medicine and cellular longevity · 2020
    Article
  18. Methylophiopogonanone A, an Ophiopogon homoisoflavonoid, alleviates high-fat diet-induced hyperlipidemia: assessment of its potential mechanism.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chuanxun YuanHefei University of Technology (South Campus), No. 198 Tunxi Road, Baohe District, Hefei City, Anhui Province, China.
Xueru ZhangHefei University of Technology (South Campus), No. 198 Tunxi Road, Baohe District, Hefei City, Anhui Province, China.
Xue LongHefei University of Technology (South Campus), No. 198 Tunxi Road, Baohe District, Hefei City, Anhui Province, China.
Jing JinHefei University of Technology (South Campus), No. 198 Tunxi Road, Baohe District, Hefei City, Anhui Province, China.
Risheng JinHefei University of Technology (South Campus), No. 198 Tunxi Road, Baohe District, Hefei City, Anhui Province, China. 1552066557@qq.com.ORCID http://orcid.org/0000-0002-2140-6507

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe hypolipidemic effect of phytosterols has been wildely recognized, but its application is limited due to its insolubility in water and low solubility in oil. In this study, β-sitosterol ester with linoleic acids and β-sitosterol self-microemulsions were prepared and their hypolipidemic effects on hyperlipidemia mice were studied.

methodsFirstly, the mice were randomly divided into normal group and model group,they were fed with basic diet and high-fat diet for 70 days respectively. After high-fat model mice was successfully established, the model group was further divided into eight groups: HFD (high-fat diet feeding), SELA-TSO(8 ml/kg, SELA:700 mg/kg), TSO (8 ml/kg), SSSM (8 ml/kg,SS:700 mg/kg), NLSM (8 ml/kg), SSHT-TSO (8 ml/kg, SS: 700 mg/kg) and SS-TSO (8 ml/kg, SS: 700 mg/kg) groups, and treated with β-sitosterol ester with linoleic acid, β-sitosterol self-microemulsion, commercial β-sitosterol health tablets and β-sitosterol powder for 35 days, respectively, and blank control groups were established. At the end of the treatment period, the blood lipid level, tissues, cholesterol and lipids in feces of mice in each group were investigated. Statistical and analytical data with SPSS 17.0 Software,statistical significance was set at p* < 0.05 and p** < 0.01 levels .

resultsThe order of lowering blood lipid effect is listed as: SSSM> SELA-TSO > SSHT-TSO > SS-TSO, which shows that β-sitosterolself-microemulsion have the highest treatment effect among the experimental groups.

conclusionsIn this study, a new formulation of β-sitosterol was developed, and its hypolipidemic effect was investigated. The results showed that β-sitosterol self-microemulsion has a good blood lipid lowering effect.

Indexed as

Administration, OralAnimalsBody WeightEatingEmulsionsFecesHyperlipidemiasHypolipidemic AgentsLinoleic AcidLipidsMaleMiceMicroscopy, Electron, TransmissionOrgan SizeSitosterolsTabletsEmulsionsgamma-sitosterolHypolipidemic AgentsLinoleic AcidLipidsSitosterolsTabletsHyperlipidemiaβ-Sitosterolβ-Sitosterol ester with linoleic acidβ-Sitosterol self-microemulsion

Identifiers

PMID31351498
PMCPMC6661088

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.